The bacterial metabolite, lipopolysaccharide (LPS), is highly immunogenic and can stimulate tumor progression through TLR4, which subsequently induces phosphatidylinositol-3-kinase (PIK3) and activation of EMT [11,12,13]. This evidence concerns the gene TLR4 and neoplasm.